FBTIX Mutual Fund (Fidelity Advisor Biotechnology Fund Class I) is managed by Fidelity Investments (US) with $745.5M in net assets. FBTIX expense ratio is 0.71%, holding 84 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTIX performance shows a YTD return of 4.42%. The 1-year return is 44.81% and the 5-year return is 8.47%. FBTIX dividend yield stands at 1.11%, paid annually.

FBTIX top holdings include Abbvie Inc (16.6%), Alnylam Pharmace (7.7%), Gilead Sciences Inc (5.5%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.7%), Fidelity Securities Lending Cash Central Fund (4.3%). View all FBTIX holdings, sector breakdown, or dividend history.

FBTIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTIX alternatives are available via the screener, along with tax-loss harvesting opportunities.